Pfizer is actively integrating artificial intelligence (AI) across various facets of its operations, from drug development and clinical trials to supply chain management. By leveraging machine learning to enhance drug discovery, expediting clinical trials, and optimizing its supply chain, Pfizer has positioned itself as a leader in AI-driven healthcare innovation. As the company continues to expand its AI capabilities, the recent appointment of Berta Rodriguez-Hervas as Chief AI and Analytics Officer marks a significant step in further solidifying this leadership.
In her new role, she will
